Loading…
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness
A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adeno...
Saved in:
Published in: | Virchows Archiv : an international journal of pathology 2005-06, Vol.446 (6), p.589-595 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3 |
container_end_page | 595 |
container_issue | 6 |
container_start_page | 589 |
container_title | Virchows Archiv : an international journal of pathology |
container_volume | 446 |
creator | TROVISCO, Vitor SOARES, Paula MAGALHAES, Joao ABROSIMOV, Alexander CAMESELLE-TEIJEIRO, José SOBRINHO-SIMOES, Manuel PRETO, Ana VIEIRA DE CASTRO, Ines LIMA, Jorge CASTRO, Patricia MAXIMO, Valdemar BOTELHO, Tiago MOREIRA, Severina MARGARIDA MEIRELES, Ana |
description | A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P |
doi_str_mv | 10.1007/s00428-005-1236-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67952192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67952192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</originalsourceid><addsrcrecordid>eNpdkd2KFDEQhYMo7jj6AN5IENSr1spPZzqXu4urwoIg63WoTqd3snQnbZJemXfxYc0ygwteVQhfnTpVh5DXDD4ygN2nDCB51wC0DeNCNfCEbJgUvOECdk_JBrRsGyXY7oy8yPkOgLOOqefkjLUauOzUhvy5OSyOYhjoktw9Ti5YR-NIL36cX9F5LVh8DJlictROMbvpQDHnaD0WN9DfvuzpgoufJkwHWvaHFP1ALSbrQ5yR7n0usfwbUdVcKPkDxVtH-7XQEMtRpKxzXFP9v00uZ3_vQi0vybMRp-xeneqW_Lz6fHP5tbn-_uXb5fl1Y0WrSoN1LTmogbm-syBB6h65FMxhJ5juWm3HTikYQWvNuezboZWqPpEpiYPtxZa8P-ouKf5aXS5m9tm6ulRwcc1G7XTLmeYVfPsfeFddh-rNdBx2gss6d0vYEbIp5pzcaJbk53ofw8A85GaOuZmam3nIzUDteXMSXvvZDY8dp6Aq8O4EYLY4jQmD9fmRU5WrLsVflKmiPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>820732424</pqid></control><display><type>article</type><title>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</title><source>Springer Nature</source><creator>TROVISCO, Vitor ; SOARES, Paula ; MAGALHAES, Joao ; ABROSIMOV, Alexander ; CAMESELLE-TEIJEIRO, José ; SOBRINHO-SIMOES, Manuel ; PRETO, Ana ; VIEIRA DE CASTRO, Ines ; LIMA, Jorge ; CASTRO, Patricia ; MAXIMO, Valdemar ; BOTELHO, Tiago ; MOREIRA, Severina ; MARGARIDA MEIRELES, Ana</creator><creatorcontrib>TROVISCO, Vitor ; SOARES, Paula ; MAGALHAES, Joao ; ABROSIMOV, Alexander ; CAMESELLE-TEIJEIRO, José ; SOBRINHO-SIMOES, Manuel ; PRETO, Ana ; VIEIRA DE CASTRO, Ines ; LIMA, Jorge ; CASTRO, Patricia ; MAXIMO, Valdemar ; BOTELHO, Tiago ; MOREIRA, Severina ; MARGARIDA MEIRELES, Ana</creatorcontrib><description>A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P<0.0001) than that of patients with conventional PTC without BRAF(V600E) (29.5 years). The BRAF (BRAF(V600E)) mutated PTC did not exhibit signs of higher aggressiveness (size, vascular invasion, extra-thyroid extension and nodal metastasis) and were in fact less often multicentric than PTC without the mutation.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-005-1236-0</identifier><identifier>PMID: 15902486</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adenocarcinoma - genetics ; Adult ; Age Factors ; Carcinoma, Papillary - genetics ; Carcinoma, Papillary, Follicular - genetics ; DNA Mutational Analysis ; Humans ; Male ; Middle Aged ; Mutation ; Polymerase Chain Reaction ; Polymorphism, Single-Stranded Conformational ; Proto-Oncogene Proteins B-raf - genetics ; Sex Factors ; Thyroid ; Thyroid Neoplasms - genetics ; Tumors</subject><ispartof>Virchows Archiv : an international journal of pathology, 2005-06, Vol.446 (6), p.589-595</ispartof><rights>2005 INIST-CNRS</rights><rights>Springer-Verlag 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</citedby><cites>FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16902795$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15902486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TROVISCO, Vitor</creatorcontrib><creatorcontrib>SOARES, Paula</creatorcontrib><creatorcontrib>MAGALHAES, Joao</creatorcontrib><creatorcontrib>ABROSIMOV, Alexander</creatorcontrib><creatorcontrib>CAMESELLE-TEIJEIRO, José</creatorcontrib><creatorcontrib>SOBRINHO-SIMOES, Manuel</creatorcontrib><creatorcontrib>PRETO, Ana</creatorcontrib><creatorcontrib>VIEIRA DE CASTRO, Ines</creatorcontrib><creatorcontrib>LIMA, Jorge</creatorcontrib><creatorcontrib>CASTRO, Patricia</creatorcontrib><creatorcontrib>MAXIMO, Valdemar</creatorcontrib><creatorcontrib>BOTELHO, Tiago</creatorcontrib><creatorcontrib>MOREIRA, Severina</creatorcontrib><creatorcontrib>MARGARIDA MEIRELES, Ana</creatorcontrib><title>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><description>A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P<0.0001) than that of patients with conventional PTC without BRAF(V600E) (29.5 years). The BRAF (BRAF(V600E)) mutated PTC did not exhibit signs of higher aggressiveness (size, vascular invasion, extra-thyroid extension and nodal metastasis) and were in fact less often multicentric than PTC without the mutation.</description><subject>Adenocarcinoma - genetics</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Carcinoma, Papillary - genetics</subject><subject>Carcinoma, Papillary, Follicular - genetics</subject><subject>DNA Mutational Analysis</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Single-Stranded Conformational</subject><subject>Proto-Oncogene Proteins B-raf - genetics</subject><subject>Sex Factors</subject><subject>Thyroid</subject><subject>Thyroid Neoplasms - genetics</subject><subject>Tumors</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpdkd2KFDEQhYMo7jj6AN5IENSr1spPZzqXu4urwoIg63WoTqd3snQnbZJemXfxYc0ygwteVQhfnTpVh5DXDD4ygN2nDCB51wC0DeNCNfCEbJgUvOECdk_JBrRsGyXY7oy8yPkOgLOOqefkjLUauOzUhvy5OSyOYhjoktw9Ti5YR-NIL36cX9F5LVh8DJlictROMbvpQDHnaD0WN9DfvuzpgoufJkwHWvaHFP1ALSbrQ5yR7n0usfwbUdVcKPkDxVtH-7XQEMtRpKxzXFP9v00uZ3_vQi0vybMRp-xeneqW_Lz6fHP5tbn-_uXb5fl1Y0WrSoN1LTmogbm-syBB6h65FMxhJ5juWm3HTikYQWvNuezboZWqPpEpiYPtxZa8P-ouKf5aXS5m9tm6ulRwcc1G7XTLmeYVfPsfeFddh-rNdBx2gss6d0vYEbIp5pzcaJbk53ofw8A85GaOuZmam3nIzUDteXMSXvvZDY8dp6Aq8O4EYLY4jQmD9fmRU5WrLsVflKmiPA</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>TROVISCO, Vitor</creator><creator>SOARES, Paula</creator><creator>MAGALHAES, Joao</creator><creator>ABROSIMOV, Alexander</creator><creator>CAMESELLE-TEIJEIRO, José</creator><creator>SOBRINHO-SIMOES, Manuel</creator><creator>PRETO, Ana</creator><creator>VIEIRA DE CASTRO, Ines</creator><creator>LIMA, Jorge</creator><creator>CASTRO, Patricia</creator><creator>MAXIMO, Valdemar</creator><creator>BOTELHO, Tiago</creator><creator>MOREIRA, Severina</creator><creator>MARGARIDA MEIRELES, Ana</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20050601</creationdate><title>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</title><author>TROVISCO, Vitor ; SOARES, Paula ; MAGALHAES, Joao ; ABROSIMOV, Alexander ; CAMESELLE-TEIJEIRO, José ; SOBRINHO-SIMOES, Manuel ; PRETO, Ana ; VIEIRA DE CASTRO, Ines ; LIMA, Jorge ; CASTRO, Patricia ; MAXIMO, Valdemar ; BOTELHO, Tiago ; MOREIRA, Severina ; MARGARIDA MEIRELES, Ana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Carcinoma, Papillary - genetics</topic><topic>Carcinoma, Papillary, Follicular - genetics</topic><topic>DNA Mutational Analysis</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Single-Stranded Conformational</topic><topic>Proto-Oncogene Proteins B-raf - genetics</topic><topic>Sex Factors</topic><topic>Thyroid</topic><topic>Thyroid Neoplasms - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TROVISCO, Vitor</creatorcontrib><creatorcontrib>SOARES, Paula</creatorcontrib><creatorcontrib>MAGALHAES, Joao</creatorcontrib><creatorcontrib>ABROSIMOV, Alexander</creatorcontrib><creatorcontrib>CAMESELLE-TEIJEIRO, José</creatorcontrib><creatorcontrib>SOBRINHO-SIMOES, Manuel</creatorcontrib><creatorcontrib>PRETO, Ana</creatorcontrib><creatorcontrib>VIEIRA DE CASTRO, Ines</creatorcontrib><creatorcontrib>LIMA, Jorge</creatorcontrib><creatorcontrib>CASTRO, Patricia</creatorcontrib><creatorcontrib>MAXIMO, Valdemar</creatorcontrib><creatorcontrib>BOTELHO, Tiago</creatorcontrib><creatorcontrib>MOREIRA, Severina</creatorcontrib><creatorcontrib>MARGARIDA MEIRELES, Ana</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TROVISCO, Vitor</au><au>SOARES, Paula</au><au>MAGALHAES, Joao</au><au>ABROSIMOV, Alexander</au><au>CAMESELLE-TEIJEIRO, José</au><au>SOBRINHO-SIMOES, Manuel</au><au>PRETO, Ana</au><au>VIEIRA DE CASTRO, Ines</au><au>LIMA, Jorge</au><au>CASTRO, Patricia</au><au>MAXIMO, Valdemar</au><au>BOTELHO, Tiago</au><au>MOREIRA, Severina</au><au>MARGARIDA MEIRELES, Ana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><addtitle>Virchows Arch</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>446</volume><issue>6</issue><spage>589</spage><epage>595</epage><pages>589-595</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P<0.0001) than that of patients with conventional PTC without BRAF(V600E) (29.5 years). The BRAF (BRAF(V600E)) mutated PTC did not exhibit signs of higher aggressiveness (size, vascular invasion, extra-thyroid extension and nodal metastasis) and were in fact less often multicentric than PTC without the mutation.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>15902486</pmid><doi>10.1007/s00428-005-1236-0</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0945-6317 |
ispartof | Virchows Archiv : an international journal of pathology, 2005-06, Vol.446 (6), p.589-595 |
issn | 0945-6317 1432-2307 |
language | eng |
recordid | cdi_proquest_miscellaneous_67952192 |
source | Springer Nature |
subjects | Adenocarcinoma - genetics Adult Age Factors Carcinoma, Papillary - genetics Carcinoma, Papillary, Follicular - genetics DNA Mutational Analysis Humans Male Middle Aged Mutation Polymerase Chain Reaction Polymorphism, Single-Stranded Conformational Proto-Oncogene Proteins B-raf - genetics Sex Factors Thyroid Thyroid Neoplasms - genetics Tumors |
title | Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A29%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20and%20prevalence%20of%20BRAF%20mutations%20are%20closely%20associated%20with%20papillary%20thyroid%20carcinoma%20histotype%20and%20patients'%20age%20but%20not%20with%20tumour%20aggressiveness&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=TROVISCO,%20Vitor&rft.date=2005-06-01&rft.volume=446&rft.issue=6&rft.spage=589&rft.epage=595&rft.pages=589-595&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-005-1236-0&rft_dat=%3Cproquest_cross%3E67952192%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=820732424&rft_id=info:pmid/15902486&rfr_iscdi=true |